Ignite Creation Date:
2024-05-06 @ 3:26 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04635995
Status:
RECRUITING
Last Update Posted:
2023-06-23
First Post:
2020-11-09
Brief Title:
Phase 1 Trial of LVGN7409 CD40 Agonist Antibody as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Sponsor:
Organization:
Lyvgen Biopharma Holdings Limited